tiprankstipranks
Advertisement
Advertisement

IMUX Stock Latest News

Immunic files to sell 458.15M shares of common stock for holders
The FlyImmunic files to sell 458.15M shares of common stock for holders
9d ago
IMUX
Immunic Regains Nasdaq Compliance, Stabilizing Listing Status
PremiumCompany Announcements
Immunic Regains Nasdaq Compliance, Stabilizing Listing Status
10d ago
8K
IMUX
Immunic regains compliance with Nasdaq
PremiumThe Fly
Immunic regains compliance with Nasdaq
10d ago
IMUX
Immunic Adds Veteran Biopharma Leader to Board
PremiumCompany Announcements
Immunic Adds Veteran Biopharma Leader to Board
11d ago
8K
IMUX
Immunic appoints Mineralys Therapeutics CEO Jon Congleton to board
PremiumThe Fly
Immunic appoints Mineralys Therapeutics CEO Jon Congleton to board
11d ago
IMUX
MLYS
Immunic initiated with a Buy at Guggenheim
PremiumThe FlyImmunic initiated with a Buy at Guggenheim
18d ago
IMUX
Immunic gets European patent for vidofludimus calcium
Premium
The Fly
Immunic gets European patent for vidofludimus calcium
1M ago
IMUX
Immunic price target lowered to $5 from $8 at H.C. Wainwright
Premium
The Fly
Immunic price target lowered to $5 from $8 at H.C. Wainwright
1M ago
IMUX
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
2M ago
AC
AMD
Why Is Immunic Stock (IMUX) Up 27% Today?
PremiumMarket News
Why Is Immunic Stock (IMUX) Up 27% Today?
2M ago
IMUX
Immunic Secures $200M Financing to Advance MS Programs
PremiumCompany Announcements
Immunic Secures $200M Financing to Advance MS Programs
2M ago
8K
IMUX
Top Analysts Just Picked These 3 ‘Strong Buy’ Stocks, 2/10/26
PremiumMarket News
Top Analysts Just Picked These 3 ‘Strong Buy’ Stocks, 2/10/26
2M ago
CEVA
2 ‘Strong Buy’ Stocks to Buy Today, 2/9/2026, According to Top Analysts
PremiumMarket News2 ‘Strong Buy’ Stocks to Buy Today, 2/9/2026, According to Top Analysts
2M ago
BTBT
IMUX
Immunic Buy Rating: Undervalued Next-Generation Oral MS Therapy with Key Phase III Catalysts and Strategic Partnership Upside
Premium
Ratings
Immunic Buy Rating: Undervalued Next-Generation Oral MS Therapy with Key Phase III Catalysts and Strategic Partnership Upside
3M ago
IMUX
Immunic Transfers Listing to Nasdaq Capital Market for Compliance
Premium
Company Announcements
Immunic Transfers Listing to Nasdaq Capital Market for Compliance
3M ago
8K
IMUX
Immunic price target lowered to $8 from $10 at H.C. Wainwright
PremiumThe Fly
Immunic price target lowered to $8 from $10 at H.C. Wainwright
5M ago
IMUX
Immunic, Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Immunic, Inc. Reports Q3 2025 Financial Results
5M ago
IMUX
Immunic’s Promising Market Potential: Buy Rating Backed by Vidofludimus Calcium’s Efficacy, Safety, and Strategic Financial Path
PremiumRatings
Immunic’s Promising Market Potential: Buy Rating Backed by Vidofludimus Calcium’s Efficacy, Safety, and Strategic Financial Path
5M ago
IMUX
Immunic reports Q3 EPS (13c), consensus (18c)
PremiumThe Fly
Immunic reports Q3 EPS (13c), consensus (18c)
5M ago
IMUX
Datadog, Trade Desk upgraded: Wall Street’s top analyst calls
PremiumThe FlyDatadog, Trade Desk upgraded: Wall Street’s top analyst calls
5M ago
U
PI
Immunic initiated with a Buy at Roth Capital
Premium
The Fly
Immunic initiated with a Buy at Roth Capital
5M ago
IMUX
IMUX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMUX Upcoming Earnings Report: What to Expect?
5M ago
IMUX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >